Based on the measurements of operating efficiency obtained from CME's historical financial statements, CME Group is doing better financially today then in previous quarter. It has a moderate odds of reporting better financial numbers in April. At present, CME's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 107.4 B, whereas Total Stockholder Equity is forecasted to decline to about 18 B. Key indicators impacting CME's financial strength include:
Investors should never underestimate CME's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CME's cash flow, debt, and profitability to make informed and accurate decisions about investing in CME Group.
Net Income
3.7 Billion
CME
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Liabilities
Total Cashflows From Investing Activities
Dividends Paid
Change To Account Receivables
Change To Inventory
Stock Based Compensation
Sale Purchase Of Stock
Other Cashflows From Investing Activities
Change To Netincome
Investments
Change Receivables
Net Borrowings
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Change To Operating Activities
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Other Liab
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Other Assets
Long Term Debt
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Common Stock
Property Plant Equipment
Short Term Investments
Current Deferred Revenue
Inventory
Short Term Debt
Intangible Assets
Good Will
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Deferred Long Term Liab
Net Tangible Assets
Long Term Debt Total
Capital Surpluse
Non Current Liabilities Other
Long Term Investments
Short Long Term Debt
Net Invested Capital
Net Working Capital
Depreciation And Amortization
Interest Expense
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Income Tax Expense
Selling General Administrative
Cost Of Revenue
Total Other Income Expense Net
Net Income Applicable To Common Shares
Research Development
Net Income From Continuing Ops
Non Recurring
Non Operating Income Net Other
Minority Interest
Tax Provision
Interest Income
Extraordinary Items
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past CME Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CME's financial statements are interrelated, with each one affecting the others. For example, an increase in CME's assets may result in an increase in income on the income statement.
Please note, the presentation of CME's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CME's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CME's management manipulating its earnings.
CME Stock Summary
CME competes with Nasdaq, SP Global, Moodys, MSCI, and Intercontinental. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people.
Specialization
Financial Services, Financial Data & Stock Exchanges
Comparative valuation techniques use various fundamental indicators to help in determining CME's current stock value. Our valuation model uses many indicators to compare CME value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CME competition to find correlations between indicators driving CME's intrinsic value. More Info.
CME Group is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CME Group is roughly 7.20 . At present, CME's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value CME by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
CME Group Systematic Risk
CME's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CME volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on CME Group correlated with the market. If Beta is less than 0 CME generally moves in the opposite direction as compared to the market. If CME Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CME Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CME is generally in the same direction as the market. If Beta > 1 CME moves generally in the same direction as, but more than the movement of the benchmark.
CME Thematic Clasifications
CME Group is part of Blockchain investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Cross-industry collection of firms that are adopting blockchain technology. Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency
This theme covers Cross-industry collection of firms that are adopting blockchain technology. Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. Get More Thematic Ideas
Today, most investors in CME Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CME's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CME growth as a starting point in their analysis.
Price Earnings To Growth Ratio
2.08
At present, CME's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
CME March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CME help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CME Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of CME Group based on widely used predictive technical indicators. In general, we focus on analyzing CME Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CME's daily price indicators and compare them against related drivers.
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.